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A B S T R A C T
Purpose: To report a case of presumed choroidal metastasis from soft tissue myoepithelial carcinoma and
highlight challenges in its diagnosis.
Observations: A 52-year-old man was referred with a two-week history of photopsia in his left eye. His back-
ground medical history included known soft tissue myoepithelial carcinoma metastatic to his bone, lung, liver
and chest wall. A large, raised, yellow choroidal lesion was identiﬁed nasal to and abutting the optic disc. This
lesion demonstrated growth 1 month after presentation. The patient died with widespread metastatic disease 5
months after initial presentation.
Conclusion and importance: Soft tissue myoepithelial carcinoma can rarely metastasise to the choroid and present
as a rapidly-growing, yellow, echodense tumour with serous retinal detachment. MRI brain can assist in tumour
evaluation and monitoring progression, while immunoperoxidase stains and molecular testing can assist with
diagnosis. The condition has an aggressive natural history and poor prognosis.
Introduction
Metastases to the choroid are an uncommon presentation of meta-
static malignancy, generally associated with advanced disease. The
most common primary sites are the lung and breast. We describe a rare
case of presumed choroidal metastasis from soft tissue myoepithelial
carcinoma, and highlight features required to make this challenging
diagnosis.
Report of case
A 52-year-old Caucasian male was referred with a six-week history
of noticing ﬂickering lights in his left eye. Visual acuities were 20/20 in
both eyes. Anterior segment examination was normal, and the vitreous
was quiet. A large (10mm diameter) raised yellow lesion was observed
nasal to and abutting the left optic disc (Fig. 1A). The right fundus was
normal.
Two weeks after initial presentation, he noticed a temporal shadow
in his left eye. The lesion documented rapid growth by 4mm at 2 weeks
(Fig. 1B) and 6mm at 4 weeks (Fig. 1C), when it was associated with an
inferior serous retinal detachment. Although the lesion was isoauto-
ﬂuorescent, the areas of subretinal ﬂuid were hyperautoﬂuorescent
(Optos PLC, Dunfermine, UK Fig. 1D). Optical coherence tomography
(CIRRUS™ 5000 HD-OCT, Carl Zeiss Meditec AG, Jena, Germany) de-
monstrated subretinal ﬂuid over the lesion and at the macula (Fig. 1E).
Brightness-scan (B-scan) ultrasonography (Eye Cubed™, Ellex, Mawson
Lakes, Australia) demonstrated an echodense lesion measuring 4.0mm
in height with overlying and inferior subretinal ﬂuid but no extraocular
extension (Fig. 1F). Magnetic resonance imaging (MRI) scan of the
brain (Sequences used: Three plane T1, T2, diﬀusion and susceptibility
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weighted and post-contrast volumetric ﬂuid attentuated inversion re-
covery) showed thickening of the choroid in the medial aspect of the
left globe with no evidence of intracranial metastases.
The patient had no signiﬁcant ocular history. However, he was re-
cently commenced on an immunotherapy trial (durvalumab and te-
melimumab) for widespread metastatic poorly diﬀerentiated soft tissue
myoepithelial carcinoma, which initially presented to his right knee
three years ago. Subsequently, he developed metastases in his bone,
liver lung and chest wall. He underwent numerous cycles of multimodal
treatment including surgery, stereotactic radiotherapy to the liver and
chemotherapy, but the results were unfruitful.
Given the rapid progression of symptoms and growth of the tumour,
he received radiotherapy to his left eye using via volumetric modulated
arc therapy technique (30Gy in 10 fractions) using stereotactic radio-
surgery setup. His vision remained stable during the treatment.1 Un-
fortunately, no choroidal biopsy or further ocular follow-up was pos-
sible as the patient's condition rapidly deteriorated; he developed two
levels of spinal cord compression from metastases in his thoracic and
lumbar spine. Sadly, he passed away in palliative care ﬁve months after
the initial ophthalmic presentation.
Discussion
The diagnosis of choroidal lesions is primarily based on clinical
examination and investigations. In our case, the patient presented with
a rapidly growing pale lesion, associated with serous retinal detach-
ment, hyper-autoﬂuorescence associated with subretinal ﬂuid and
echodensity on B-scan ultrasonography. These features in conjunction
with a known history of biopsy proven metastatic soft tissue myoe-
pithelial carcinoma make choroidal metastasis from this tumour by far
the most likely diagnosis.
Metastatic soft tissue myoepithelial carcinoma to the choroid is
exceedingly rare. A search of PubMed, MEDLINE, and the Cochrane
Library with keywords “myoepithelial carcinoma”, “soft tissue myoe-
pithelioma”, “metastasis” and “choroid” revealed no previous cases.
There has been one report of soft tissue myoepithelial carcinoma me-
tastatic to the orbit of an 11-year-old boy from his left thigh, who died
from widespread metastases.2 Soft tissue myoepithelial carcinoma
should be recognised as a potential primary site that can cause metas-
tases to the choroids since 34% of patients presenting with choroidal
metastases have no known primary at the time of ocular presentation,
and in half of these, a primary site is never found.3
Diﬀerential diagnoses considered included amelanotic choroidal
melanoma and choroidal metastasis from another primary. Amelanotic
melanoma is less likely given the rapid growth of the tumour and
echodensity on B-scan ultrasound. The mean time for choroidal mela-
noma to double in size is 128.2–291.6 days for mixed and spindle cell
types respectively,4 compared to only 31 days in our patient. Most
choroidal melanomas are echolucent on B-scan ultrasound. No other
potential primary neoplasm was detected on systemic investigations,
making this also unlikely.
The classiﬁcation of myoepithelial tumours of soft tissue is still
evolving, and the speciﬁc histopathology has not been fully elucidated.5
It aﬀects male and females equally with the peak incidence in the third
to ﬁfth decades.6,7 Typically it presents as a painless or painful mass,
commonly found in the extremities, especially in the lower limbs, fol-
lowed by the neck, head and trunk.6,7 The morphology and im-
munophenotype are similar to their counterparts in the salivary gland.
They are composed of epithelial and/or myoepithelial cellular elements
present in varying proportions usually in a hyalinised to chon-
dromyxoid stroma and may show foci of ductal diﬀerentiation. They
show overlap with mixed tumour of skin and soft tissue. Current no-
menclature includes that of soft tissue myoepithelioma, which have
bland “benign” appearing morphology and morphologically malignant
forms which are called myoepithelial carcinoma.7–9
Although the vast majority of such neoplasms behave benignly, a
minority of cases may recur locally and metastasise. Currently, no
morphologic features reliably predict behaviour, however cytological
atypia represents the most reliable prognostic parameter.6 Soft tissue
myoepithelial carcinoma behaves aggressively with a 39% recurrence
rate, and 52% of patients may develop distant metastases.7
In our case, the patient initially presented with a soft tissue lesion
medial to the right patellar tendon. Histopathology revealed a malig-
nant tumour, the morphology of which was reminiscent of a poorly
diﬀerentiated large cell carcinoma in which irregular islands of cells
were present in small sheets and strands, the latter lying in the hyali-
nised stroma. Immunoperoxidase stains identiﬁed expression of a
variety of keratins including cytokeratin (CK) 8/18 and CK 7 with focal
expression of CK AE1/3, CK 5/6 and CK 19. Polyclonal carcinoem-
bryonic antigen (CEA) and epithelial membrane antigen (EMA) was
also positive, and co-expression of S100 protein was identiﬁed in areas.
CK 14 and p63 were also negative as were a variety of other markers
including endothelial and myoid markers. Integrase interactor 1 (INI1)
nuclear staining was retained (Fig. 2). The diﬀerential diagnoses in-
cluded metastatic carcinoma, poorly diﬀerentiated synovial sarcoma
and, given the location in the tibia, an unusual form of adamantinoma
like Ewing sarcoma. Fluorescence in situ hybridization (FISH) testing
for SS18 and Ewing sarcoma breakpoint regional 1 (EWSR1) were ne-
gative, excluding Ewing sarcoma and synovial sarcoma.
The diagnosis of poorly diﬀerentiated soft tissue myoepithelial
carcinoma can be challenging as observed in this case.
Immunoperoxidase stains are often used to assist with diagnosis,
usually associated with co-expression of keratins, S-100, p63 and myoid
markers such as actin, calponin, caldesmon and desmin.8,9 Molecular
ﬁndings such as rearrangements in EWSR1 on FISH testing can also
assist in diagnosis but is only present in 50% of cases and not manda-
tory for diagnosis.10–12 The morphological features and co-expression of
cytokeratins and S100 protein with the absence of a primary tumour
Fig. 1. A large raised yellow choroidal lesion is present nasal to and abutting
the left optic disc (A). The lesion grew by 4mm (B) and 6mm (C) in diameter 2
and 4 weeks after presentation respectively. The lesion is isoautoﬂuorescent but
the areas of subretinal ﬂuid are hyperautoﬂuorescent (D). Optical coherence
tomography demonstrates a small amount of subretinal ﬂuid at the macula (E).
B-scan ultrasonography shows an echodense tumour measuring 4.0mm in
height with overlying and inferior subretinal ﬂuid but no extraocular extension
(F).
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elsewhere were consistent with of a poorly diﬀerentiated soft tissue
myoepithelial carcinoma in this case.
The prognosis of soft tissue myoepithelial carcinoma is poor.
Current literature of patients treated with radiation and chemotherapy
in recurrent and metastatic of soft tissue myoepithelial carcinoma have
been reported to be unsuccessful.
Conclusion
In summary, we report a rare case of presumed choroidal metastasis
from soft tissue myoepithelial carcinoma that presented as a rapidly-
growing, yellow, echo-dense choroidal tumour with serous retinal de-
tachment. The lesion is isoautoﬂuorescent, but hyperautoﬂuorescence
can be seen in areas of subretinal ﬂuid. MRI brain can assist in tumour
evaluation and monitoring progression, while immunoperoxidase stains
and molecular testing can assist with conﬁrming this diﬃcult to diag-
nose condition. It is important to include this condition in the diﬀer-
ential diagnosis of choroidal metastases because one-third of choroidal
metastases have no known primary at the time of presentation. Soft
tissue myoepithelial carcinoma has a highly aggressive natural history,
is resistant to current anti-neoplastic treatments and has a poor prog-
nosis.
Patient consent
Patient consent: Patient provided both orally and written consent
for the information gathered and the publication of his case. This report
does not contain any personal information that could lead to identiﬁ-
cation of the patient.
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Fig. 2. Sheets and strands of tumour cells with epithelial morphology in a fo-
cally hyalinised stroma (A). Higher power shows highly atypical cells with
vescicular nuclei, prominent nucleoli and several mitoses (arrow) (B).
Cytokeratin 8/18 expression (C) and co-expression of S100 protein (D) sup-
porting a myoepithelial tumour.
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